ATEC: Strong volume growth, innovation, and margin gains support robust long-term financial targets
Procedural volumes and surgeon adoption remain strong, supporting high revenue growth and robust financial guidance through 2027. Product innovation, especially with Valence and EOS Insight, is driving clinical differentiation and operational efficiency. Strategic moves like the Theradaptive acquis…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.